Hello,
Be sure to comment, follow, like, and check out my profile for more trade ideas!
About Aptorum Group
Aptorum Group Limited (Nasdaq:APM) is a pharmaceutical company dedicated to developing and commercializing novel therapeutics to tackle unmet medical needs. Aptorum Group’s current drug pipeline includes indications in orphan diseases, infectious diseases and metabolic diseases, a number of which are targeted to enter clinical trial phases in H2 2020. Aptorum Group is also launching a women’s health supplement, Dioscorea Opposita Bioactive Nutraceutical Tablets, which will be commercialized soon.
Exclusive Interview with President of Aptorum Group
Good Luck
Cheers!
Be sure to comment, follow, like, and check out my profile for more trade ideas!
About Aptorum Group
Aptorum Group Limited (Nasdaq:APM) is a pharmaceutical company dedicated to developing and commercializing novel therapeutics to tackle unmet medical needs. Aptorum Group’s current drug pipeline includes indications in orphan diseases, infectious diseases and metabolic diseases, a number of which are targeted to enter clinical trial phases in H2 2020. Aptorum Group is also launching a women’s health supplement, Dioscorea Opposita Bioactive Nutraceutical Tablets, which will be commercialized soon.
Exclusive Interview with President of Aptorum Group
Good Luck
Cheers!
Comment:
Be aware that this is just the set-up for an expanded flat. We could see this hover at the bottom or just break the structure making this TA void!
